Brain Metastases
- Metastases are the most common brain tumors in adults — far more common than any primary brain tumor.
- The classic look is multiple enhancing lesions at the gray–white junction, with way more swelling than the lesion's size would suggest.
- Lung, breast, and melanoma are the usual senders; melanoma and renal/thyroid mets love to bleed.
- Contrast-enhanced MRI is the workhorse — it finds the small ones a CT will quietly miss.
- A single metastasis can perfectly impersonate a primary tumor; the body's whole story is the tiebreaker.
Here's a humbling fact: when an adult has a tumor in the brain, the smart money usually isn't on a tumor that started in the brain. It's on a tumor that started somewhere else — a lung, a breast, a patch of skin — and mailed a copy upstairs. Metastases are the most common brain tumors in adults, and they tend to announce themselves in groups.
Where they land and why
Tumor cells travel in the bloodstream like little passengers, and they get stuck where the plumbing narrows. In the brain, the arteries taper sharpest right at the gray–white junction — the border where the bark-like gray matter meets the white matter underneath. So that's where most mets lodge, like leaves catching at a bend in a gutter. They also pile up in the watershed zones and show a soft preference for the back of the brain.
Practically, this gives you a pattern to hunt for: small round lesions sitting right at that gray–white border, often several at once. Roughly 80% end up in the cerebral hemispheres, with the rest scattered across the cerebellum and brainstem.
The signature: edema out of proportion
The most useful tell isn't the lesion itself — it's the swelling around it. Metastases provoke vasogenic edema that is wildly out of proportion to their size: a pea-sized nodule can sit at the center of a fist-sized blob of edema. On MRI that edema lights up bright on T2 and FLAIR and fingers its way through the white matter while politely sparing the gray matter (it tracks the white-matter highways).
When you see a small enhancing lesion drowning in edema that seems far too big for it, think metastasis. Primary gliomas can swell too, but the "tiny tumor, enormous edema" mismatch is a classic met fingerprint.
How they enhance
Most mets break down the blood–brain barrier, so they take up contrast eagerly. The enhancement pattern depends on size: small ones tend to enhance solidly, while larger ones outgrow their blood supply, die in the middle, and go ring-enhancing — a bright rim around a dark necrotic core.
That ring is where they get sneaky, because a met ring and an abscess ring and a glioblastoma ring can look identical on a plain post-contrast image. Diffusion-weighted imaging (DWI) is the referee: a pyogenic abscess traps water and glows bright on DWI with a dark core on ADC, while a necrotic tumor usually does not. (More on reading these sequences in Approach to Brain MRI.)
A solitary ring-enhancing met is the great impersonator. It can look exactly like a high-grade glioma or an abscess. Don't anchor on the brain image alone — the patient's history and a hunt for the primary tumor settle far more of these cases than any single sequence.
The ones that bleed
A few primaries are notorious for hemorrhagic metastases. The memory hook a lot of trainees use is that melanoma, renal cell, thyroid, and choriocarcinoma are the classic bleeders. Melanoma earns a double mention: its melanin pigment can be intrinsically bright on T1 before you even give contrast, which is an unusual and useful clue. So if you find multiple brain lesions with blood products and no trauma to explain them, the primary search shifts toward that group.
One lesion vs. many
| Scenario | What it suggests | Why it matters |
|---|---|---|
| Multiple enhancing lesions at the gray–white junction | Metastases, until proven otherwise | Pattern is strong enough to drive the workup toward staging the body |
| Single enhancing lesion | Could be a met, but a primary tumor is genuinely on the table | Tiebreaker is the clinical context and body imaging, not the brain alone |
About half of brain mets are solitary at presentation, which is exactly why a single lesion can't be waved off as "obviously metastatic." When it's truly one lesion in a patient with no known cancer, you're often back to chasing a primary glioma vs. a lone metastasis — and that question gets answered by imaging the rest of the body, not by squinting harder at the head.
Why MRI, and why with contrast
CT will catch the big, obvious, or bleeding lesions, but it quietly misses the small ones — and "how many lesions are there" changes the treatment plan (one resectable spot vs. whole-brain therapy). Contrast-enhanced MRI is the standard of care for finding and counting brain metastases, because the small enhancing nodules pop on post-contrast T1 in a way they simply don't on CT.
Don't forget the lining. Tumor can also coat the surfaces of the brain and spinal cord — leptomeningeal disease — showing up as enhancement that drapes over the gyri and dips into the sulci rather than forming a discrete ball. It's easy to overlook and changes management, so scan the surfaces, not just the substance.
If you remember one thing: in an adult, multiple enhancing lesions at the gray–white junction with too much edema is metastatic disease until the rest of the body proves otherwise. The brain is just where the story ended up — your job is often to figure out where it began.